Cargando…
Evidence that multiple myeloma may be regulated by homeostatic control mechanisms: correlation of changes in the number of clonogenic myeloma cells in vitro with clinical response.
Myeloma colonies (MY-CFUc) could be grown in vitro for 6 months (median time) after a group of 12 myeloma patients had reached complete remission (CR). In a second group of 25 patients MY-CFUc increased in 17/25 and GM-CFUc in 20/25 patients after cyclophosphamide even though 24/25 patients had a pa...
Autores principales: | Maitland, J. A., Millar, B. C., Bell, J. B., Montes, A., Treleaven, J., Gore, M. E., McElwain, T. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971273/ https://www.ncbi.nlm.nih.gov/pubmed/2328211 |
Ejemplares similares
-
Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients.
por: Forgeson, G. V., et al.
Publicado: (1988) -
Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy.
por: Selby, P. J., et al.
Publicado: (1980) -
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
por: Kukreja, Anjli, et al.
Publicado: (2006) -
Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction
por: Tian, Faqing, et al.
Publicado: (2019) -
Natural killer cells efficiently target multiple myeloma clonogenic tumor cells
por: Leivas, Alejandra, et al.
Publicado: (2021)